Sign up for otohns.net!  4/18/2014

  News
This weeks' news
Media Page
  Clinical Resources
Facial Plastics & Reconstructive Surgery
Head & Neck Oncology
Laryngology
Otology / Neurotology
Pediatric Otolaryngology
Practice Management
Rhinology
Snoring & Sleep Apnea
  Forums
otohns
pedi-oto
  Library
Medline Knowledge Finder
otohns Bookstore
UTMB Grand Rounds
Endoscopic Sinus Surgery
Congress Reporter
  Image Library
Disorders of The Larynx
Facial Fractures
Floor of Mouth
Line Art

  Conferences
Conference Calendar
Conference Reporter
  Patient Education
  Resources and Links
otohns Job Search
otohns Vendor Database
Build a Web Page
  otohns Directories
Associations and Organizations
  Financial Links
  Britannica.com
  DailyStocks.com
  EquityWeb
  Hoover's
  InvestorNet
  JustQuotes.com
  JustQuoteMe.com
  MSN MoneyCentral
  TradingDay.com
  Wall Street Research Net
  Yahoo! Finance
  Advisory Boards
All Board Members
  About Us
Our Staff
About Otohns.net
About MediSpecialty.com
How to Get Involved
Become a Sponsor
Terms and Conditions
Privacy Statement
  Help!
Acronym Expander
  Contact Us
  Home

[Hon Code]We subscribe to the HONcode principles of the Health On the Net Foundation

ePocrates secures Series C round of funding

Financing

Date: 8/19/2002

2002 AUG 19 - (NewsRx.com & NewsRx.net) -- ePocrates has secured a round of funding from several prominent healthcare and technology focused venture capital firms. Participants in the round of funding include Sprout Group, Interwest Partners, Three Arch, Draper Fisher Jurvetson, and Bay City Capital. The ePocrates network provides physicians using Palm OS compatible handheld devices with quick point-of-care access to critical drug information, such as dosing, drug interactions, and contraindications. Since its launch in November 1999, the ePocrates network has grown at an unprecedented rate, with the network expanding by over 800 new users per day. The ePocrates Rx drug reference guide has been demonstrated to improve patient care and increase physician efficiency and patient satisfaction. The large size of the ePocrates network has allowed ePocrates to develop an extensive client roster that includes 9 out of the top 10 pharmaceutical companies and a variety of biotechnology, medical device, managed care, clinical trial and market research companies. Companies working with ePocrates are able to provide messaging and content hosting services to various physician specialties and healthcare professionals at the point of care. This round of funding will allow ePocrates to further develop and deploy new applications, while providing the company sufficient funds to reach critical milestones for the next steps in financing and expansion. The company is currently improving its current products and services and is also developing new applications that will be available later this year. This article was prepared by Health & Medicine Week editors from staff and other reports.

Copyright: ©Copyright 2002, Health & Medicine Week via NewsRx.com & NewsRx.net
www.NewsRx.net


A service of © 1996-2008 all rights reserved